Form 4: LifeMD Director Roberto Simon Receives Stock Grant

LifeMD, Inc. Director Roberto Simon was granted 22,365 restricted stock units, which are scheduled to vest on June 1, 2026, increasing his total beneficial ownership to 183,175 shares.

Summary

• Roberto Simon, a Director of LifeMD, Inc. (LFMD), acquired 22,365 shares of common stock.
• The transaction occurred on October 2, 2025, and involved restricted stock units (RSUs).
• These RSUs were granted at a price of $0 per share, indicating a compensation-related award.
• The acquired RSUs are scheduled to vest on June 1, 2026.
• Following this transaction, Mr. Simon's total beneficial ownership in LifeMD, Inc. increased to 183,175 shares of common stock.

Sentiment

Score: 6

Explanation: Slightly positive due to increased insider ownership aligning interests, but a routine compensation event.

Positives

• Increased alignment of a director's interests with those of shareholders through additional equity ownership.
• The grant of restricted stock units is a common form of executive and director compensation, indicating ongoing commitment.

Negatives

• The grant of restricted stock units, while common, can lead to future share dilution upon vesting, though the amount here is relatively small.

Risks

• Future dilution of existing shares upon the vesting of the restricted stock units.
• The value of the granted shares is subject to the future market performance of LifeMD, Inc.'s common stock.

Future Outlook

The 22,365 restricted stock units granted to Director Roberto Simon are scheduled to vest on June 1, 2026, at which point they will convert into common stock.

Industry Context

The grant of restricted stock units to a director is a standard practice in corporate compensation, aiming to align the interests of management and board members with long-term shareholder value. This is a common mechanism used across various industries to incentivize performance and retention.

Related Party Transactions

• The transaction involves an equity grant to a director, which is a common form of compensation and an insider transaction.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon vesting, but also increased alignment of director's interests with long-term share performance.
• Director (Roberto Simon): Receives equity compensation, incentivizing long-term commitment and performance.

Next Steps

• Vesting of the 22,365 restricted stock units on June 1, 2026.

Key Dates

Keywords

LifeMD, LFMD, Roberto Simon, Director, Restricted Stock Units, RSU, Insider Transaction, Form 4, Equity Grant, Beneficial Ownership